According to the tenth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) series, community pharmacists continue to suffer discrimination, harassment, and aggression on the job, but more are pushing back with legal action.

Researchers of a new study published in JAMA sought to investigate the neonatal and maternal safety of buprenorphine plus naloxone compared with buprenorphine only in pregnant patients with OUD.

CDC released a 2024 update to its evidence-based guidance for health care providers related to contraceptive use by their patients.

Interventions led by pharmacists and community health workers are most likely to help patients with hypertension achieve disease control, according to research published July 19, 2024, in the American Heart Association’s (AHA’s) journal Circulation: Cardiovascular Quality and Outcomes.

On April 22, 2024, Iowa governor Kim Reynolds signed a bill into law that updates the state’s pharmacy practice act and puts in place a standard of care regulatory framework, aligning pharmacists with other providers in the state.